Lanzhou Foci Pharmaceutical Co.Ltd(002644)
2021 profit distribution plan
Dear directors
According to the standard unqualified audit report audited and issued by Daxin Certified Public Accountants (special general partnership), the company realized the parent company’s net profit of 9325895607 yuan in 2021, accrued 10% legal surplus reserve of 932589561 yuan in accordance with the company law and the articles of association, and the undistributed profit at the end of 2021 was 65452679989 yuan. In order to fully protect the interests of investors and maximize shareholders’ income, combined with the future development of the company, the company plans to implement the following profit distribution plan:
Based on the total share capital of 510657000 shares as of December 31, 2021, the company will distribute cash dividends of RMB 0.10 (including tax) to all shareholders for every 10 shares, with a total cash distribution of RMB 510657000. No bonus shares will be given and no capital reserve will be converted into share capital.
This plan needs to be submitted to the general meeting of shareholders of the company for deliberation, and all directors are invited to consider it.
Lanzhou Foci Pharmaceutical Co.Ltd(002644) board of directors
March 15, 2022
